- Home
- BBIO vs JHX Comparison
BBIO vs JHX Comparison
Compare BBIO & JHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- JHX
- Stock Information
- Founded
- BBIO 2015
- JHX 1888
- Country
- BBIO United States
- JHX Ireland
- Employees
- BBIO N/A
- JHX N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- JHX Building Materials
- Sector
- BBIO Health Care
- JHX Industrials
- Exchange
- BBIO Nasdaq
- JHX Nasdaq
- Market Cap
- BBIO 12.5B
- JHX 11.8B
- IPO Year
- BBIO 2019
- JHX N/A
- Fundamental
- Price
- BBIO $71.90
- JHX $19.63
- Analyst Decision
- BBIO Strong Buy
- JHX Strong Buy
- Analyst Count
- BBIO 19
- JHX 9
- Target Price
- BBIO $74.79
- JHX $28.60
- AVG Volume (30 Days)
- BBIO 2.4M
- JHX 7.9M
- Earning Date
- BBIO 10-29-2025
- JHX 11-17-2025
- Dividend Yield
- BBIO N/A
- JHX N/A
- EPS Growth
- BBIO N/A
- JHX N/A
- EPS
- BBIO N/A
- JHX 0.40
- Revenue
- BBIO $353,780,000.00
- JHX $4,116,899,999.00
- Revenue This Year
- BBIO $123.32
- JHX $21.70
- Revenue Next Year
- BBIO $73.46
- JHX $16.85
- P/E Ratio
- BBIO N/A
- JHX $58.66
- Revenue Growth
- BBIO 62.46
- JHX 4.60
- 52 Week Low
- BBIO $25.34
- JHX $16.46
- 52 Week High
- BBIO $72.26
- JHX $29.83
- Technical
- Relative Strength Index (RSI)
- BBIO 71.58
- JHX 56.13
- Support Level
- BBIO $64.41
- JHX $17.58
- Resistance Level
- BBIO $67.71
- JHX $19.10
- Average True Range (ATR)
- BBIO 2.80
- JHX 0.60
- MACD
- BBIO 0.35
- JHX 0.30
- Stochastic Oscillator
- BBIO 95.73
- JHX 97.36
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.